202 related articles for article (PubMed ID: 11869938)
1. Acquired von Willebrand factor abnormalities in myeloproliferative disorders and other hematologic diseases: a retrospective analysis by a single institution.
Sánchez-Luceros A; Meschengieser SS; Woods AI; Blanco AN; Kempfer AC; Casais P; Salviú MJ; Lazzari MA
Haematologica; 2002 Mar; 87(3):264-70. PubMed ID: 11869938
[TBL] [Abstract][Full Text] [Related]
2. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
[TBL] [Abstract][Full Text] [Related]
3. Acquired von Willebrand syndrome: data from an international registry.
Federici AB; Rand JH; Bucciarelli P; Budde U; van Genderen PJ; Mohri H; Meyer D; Rodeghiero F; Sadler JE;
Thromb Haemost; 2000 Aug; 84(2):345-9. PubMed ID: 10959711
[TBL] [Abstract][Full Text] [Related]
4. Acquired von Willebrand's syndrome: a single institution experience.
Kumar S; Pruthi RK; Nichols WL
Am J Hematol; 2003 Apr; 72(4):243-7. PubMed ID: 12666134
[TBL] [Abstract][Full Text] [Related]
5. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome.
Federici AB
Hum Immunol; 2005 Apr; 66(4):422-30. PubMed ID: 15866707
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of acquired von Willebrand syndrome.
Federici AB; Mannucci PM
Clin Adv Hematol Oncol; 2003 Mar; 1(3):169-75. PubMed ID: 16224398
[TBL] [Abstract][Full Text] [Related]
7. Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry.
Budde U; Bergmann F; Michiels JJ
Semin Thromb Hemost; 2002 Apr; 28(2):227-38. PubMed ID: 11992245
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of acquired von Willebrand syndrome.
Tiede A
Thromb Res; 2012 Dec; 130 Suppl 2():S2-6. PubMed ID: 23439003
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome.
Luboshitz J; Lubetsky A; Schliamser L; Kotler A; Tamarin I; Inbal A
Thromb Haemost; 2001 May; 85(5):806-9. PubMed ID: 11372672
[TBL] [Abstract][Full Text] [Related]
10. Association of acquired von Willebrand syndrome with AL amyloidosis.
Kos CA; Ward JE; Malek K; Sanchorawala V; Wright DG; O'Hara C; Connors L; Skinner M; Seldin DC
Am J Hematol; 2007 May; 82(5):363-7. PubMed ID: 17205535
[TBL] [Abstract][Full Text] [Related]
11. [Acquired von Willebrand syndrome].
Franchini M
Recenti Prog Med; 2006; 97(7-8):417-21; quiz 440. PubMed ID: 16913181
[TBL] [Abstract][Full Text] [Related]
12. Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update.
Federici AB; Budde U; Castaman G; Rand JH; Tiede A
Semin Thromb Hemost; 2013 Mar; 39(2):191-201. PubMed ID: 23397553
[TBL] [Abstract][Full Text] [Related]
13. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568
[TBL] [Abstract][Full Text] [Related]
14. Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders.
Federici AB
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S48-58. PubMed ID: 16427386
[TBL] [Abstract][Full Text] [Related]
15. Acquired von Willebrand syndrome: diagnostic problems and therapeutic options.
Eikenboom JC; Tjernberg P; Van Marion V; Heering KJ
Am J Hematol; 2007 Jan; 82(1):55-8. PubMed ID: 16986130
[TBL] [Abstract][Full Text] [Related]
16. Acquired von Willebrand syndrome--report of 10 cases and review of the literature.
Nitu-Whalley IC; Lee CA
Haemophilia; 1999 Sep; 5(5):318-26. PubMed ID: 10583513
[TBL] [Abstract][Full Text] [Related]
17. Acquired von Willebrand disease.
Kumar S; Pruthi RK; Nichols WL
Mayo Clin Proc; 2002 Feb; 77(2):181-7. PubMed ID: 11838652
[TBL] [Abstract][Full Text] [Related]
18. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
[TBL] [Abstract][Full Text] [Related]
20. Acquired von Willebrand's syndrome resulting from untreated hypothyroidism in two prepubertal girls.
Galli-Tsinopoulou A; Stylianou C; Papaioannou G; Nousia-Arvanitakis S
Haemophilia; 2006 Nov; 12(6):687-9. PubMed ID: 17083524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]